| For: | Grotz TE, Royal RE, Mansfield PF, Overman MJ, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF. Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade. World J Gastrointest Oncol 2017; 9(9): 354-362 [PMID: 28979717 DOI: 10.4251/wjgo.v9.i9.354] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v9/i9/354.htm |
| Number | Citing Articles |
| 1 |
Mikael L. Soucisse, Joshua Lansom, Mohammad S. Alshahrani, David L. Morris. Mucinous appendiceal neoplasms with or without pseudomyxoma peritonei: a review. ANZ Journal of Surgery 2020; 90(10) doi: 10.1111/ans.16185
|
| 2 |
Laura M. Legué, Geert-Jan Creemers, Ignace H.J.T. de Hingh, Valery E.P.P. Lemmens, Clément J. Huysentruyt. Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei. Clinical Colorectal Cancer 2019; 18(1) doi: 10.1016/j.clcc.2018.11.007
|
| 3 |
Adam C. Fields, Pamela W. Lu, George Z. Li, Vanessa Welten, Joshua S. Jolissaint, Benjamin M. Vierra, Lily V Saadat, Abby C. Larson, Rachel B. Atkinson, Nelya Melnitchouk. Current practices and future steps for hyperthermic intraperitoneal chemotherapy. Current Problems in Surgery 2020; 57(3) doi: 10.1016/j.cpsurg.2019.100727
|
| 4 |
Jackson Baril, Trang Nguyen. Complex General Surgical Oncology. 2025; doi: 10.1007/978-3-031-88954-7_15
|
| 5 |
Lamia Azizi, Philippe Attieh, Noura Chamchoum, Elie Chamchoum, George Ghaleb, Mehsen Azizi, Karam Karam. Appendiceal mucinous adenocarcinoma presenting as cecal intussusception: A rare case report. Medical Reports 2025; 14 doi: 10.1016/j.hmedic.2025.100400
|
| 6 |
Vasileios Tsagkalidis, Jennie K. Choe, Toni Beninato, Mariam F. Eskander, Miral S. Grandhi, Haejin In, Timothy J. Kennedy, Russell C. Langan, Jason C. Maggi, Henry A. Pitt, H. Richard Alexander, Brett L. Ecker. Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies. Annals of Surgical Oncology 2024; 31(7) doi: 10.1245/s10434-024-15233-9
|
| 7 |
Yosef Y. Nasseri, Ruoyan Zhu, Christine Sutanto, Christina Wai, Jason S. Cohen, Joshua Ellenhorn, Avo Artinyan. Role of right hemicolectomy in patients with low-grade appendiceal mucinous adenocarcinoma. The American Journal of Surgery 2019; 218(6) doi: 10.1016/j.amjsurg.2019.07.035
|
| 8 |
Muhammad Talha Waheed, Ibrahim Malik, Andrew M. Blakely, Yasmine Zerhouni, Mark Hanna, Kurt Melstrom, Lily L. Lai, Andreas M. Kaiser, Lwin Thinzar, Isaac B. Paz, Mustafa Raoof. Who should get a right colectomy in low-grade appendiceal adenocarcinomas? Association of lymphovascular invasion and nodal metastases. Surgery 2024; 176(3) doi: 10.1016/j.surg.2024.05.040
|
| 9 |
Nick C. Levinsky, Mackenzie C. Morris, Koffi Wima, Jeffrey J. Sussman, Syed A. Ahmad, Jordan M. Cloyd, Charles Kimbrough, Keith Fournier, Andrew Lee, Sean Dineen, Sophie Dessureault, Jula Veerapong, Joel M. Baumgartner, Callisia Clarke, Mohammad Y. Zaidi, Charles A. Staley, Shishir K. Maithel, Jennifer Leiting, Travis Grotz, Laura Lambert, Ryan J. Hendrix, Sean Ronnekleiv-Kelly, Courtney Pokrzywa, Mustafa Raoof, Oliver S. Eng, Fabian M. Johnston, Jonathan Greer, Sameer H. Patel. Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. Journal of Gastrointestinal Surgery 2020; 24(1) doi: 10.1007/s11605-019-04336-4
|
| 10 |
Paula Marincola Smith, Ashlee Seldomridge, Yi-Ju Chiang, Michael G. White, Yun Song, Christopher Scally, Paul F. Mansfield, Keith F. Fournier, Beth A. Helmink. Outcomes following diagnostic laparoscopy in patients with peritoneal carcinomatosis deemed ineligible for cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) due to disease burden. Surgical Oncology Insight 2025; 2(2) doi: 10.1016/j.soi.2025.100150
|
| 11 |
Erika Belmont, Varun V. Bansal, Mahmoud M.G. Yousef, Mohammad A. Zeineddine, David Su, Ankit Dhiman, Chih-Yi Liao, Blasé Polite, Oliver S. Eng, Keith F. Fournier, Michael G. White, Kiran K. Turaga, John Paul Shen, Ardaman Shergill. Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers. JCO Precision Oncology 2024; (8) doi: 10.1200/PO.23.00531
|
| 12 |
Yu-Lin Lin, Da-Zhao Xu, Xin-Bao Li, Feng-Cai Yan, Hong-Bin Xu, Zheng Peng, Yan Li. Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines. Orphanet Journal of Rare Diseases 2021; 16(1) doi: 10.1186/s13023-021-01723-6
|
| 13 |
Beijiao Wu, Ling Ai. Pregnancy complicated with low-grade appendiceal mucinous tumor: A case report. Medicine 2025; 104(37) doi: 10.1097/MD.0000000000044354
|
| 14 |
Daniel J. Gironda, Richard A. Erali, Steven D. Forsythe, Ashok K. Pullikuth, Rui Zheng-Pywell, Kathleen A. Cummins, Shay Soker, Xianyong Gui, Edward A. Levine, Konstantinos I. Votanopoulos, Lance D. Miller. The Genomic Topography of Appendiceal Cancers: Our Current Understanding, Clinical Perspectives, and Future Directions. Cancers 2025; 17(19) doi: 10.3390/cancers17193275
|
| 15 |
Juan P. Cata, Linh T. Nguyen, Ifeyinwa C. Ifeanyi-Pillette, Antoinette Van Meter, Lori A. Dangler, Lei Feng, Pascal Owusu-Agyemang. An assessment of the survival impact of multimodal anesthesia/analgesia technique in adults undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a propensity score matched analysis. International Journal of Hyperthermia 2019; 36(1) doi: 10.1080/02656736.2019.1574985
|
| 16 |
Samer S. AlMasri, Abdulrahman Y. Hammad, Aatur D. Singhi, Alessandro Paniccia, Amer H. Zureikat, James P. Celebrezze, Haroon A. Choudry, Ibrahim Nassour. Appendectomy Is Oncologically Equivalent to Right Hemicolectomy for Well-Differentiated T1 Appendiceal Adenocarcinoma. Diseases of the Colon & Rectum 2023; 66(1) doi: 10.1097/DCR.0000000000002089
|
| 17 |
L Martín-Román, P Lozano, W Vásquez, N Palencia, Y Gómez, M J Fernández-Aceñero, L González-Bayón. Defining stage in mucinous tumours of the appendix with peritoneal dissemination: the importance of grading terminology: systematic review. BJS Open 2021; 5(4) doi: 10.1093/bjsopen/zrab059
|
| 18 |
Xin Zhao, Xinbao Li, Yulin Lin, Ru Ma, Ying Zhang, Dazhao Xu, Yan Li. Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Cancer Medicine 2023; 12(3) doi: 10.1002/cam4.5138
|
| 19 |
Nohtseu Vadzim, Saarah Dhilfer Allahudeen, Ibrahim Rasheed Rijwanul Haq. Peritoneal carcinomatosis of unknown primary site: a case report of metastatic mucinous adenocarcinoma. International Surgery Journal 2026; 13(5) doi: 10.18203/2349-2902.isj20261177
|
| 20 |
Puja Sakhuja, K. P. Aravindan. Surgical Pathology of the Gastrointestinal System. 2022; doi: 10.1007/978-981-16-6395-6_21
|
| 21 |
Melissa W. Taggart, Wai Chin Foo, Sun Mi Lee. Oncological Surgical Pathology. 2020; doi: 10.1007/978-3-319-96681-6_12
|
| 22 |
Michael G. White, Mohammad A. Zeineddine, Eleanor A. Fallon, Fadl A. Zeineddine, Julia Dansby, Saikat Chowdhury, Nicholas Hornstein, Abdelrahman Yousef, Mahmoud Yousef, Neal Bhutiani, Yue Gu, Bryan Kee, Arvind Dasari, Michael J. Overman, Kanwal Raghav, Scott Kopetz, Abhineet Uppal, Melissa Taggart, Timothy Newhook, Keith Fournier, Beth Helmink, Leylah M. Drusbosky, John Paul Shen. The Landscape of ctDNA in Appendiceal Adenocarcinoma. Clinical Cancer Research 2025; 31(3) doi: 10.1158/1078-0432.CCR-24-2474
|
| 23 |
Jiahua Zhou, Yeye Yi, Congjun Wang, Cheng Su, Yige Luo. Identification of a 3‑mRNA signature as a novel potential prognostic biomarker in patients with ovarian serous cystadenocarcinoma in G2 and G3. Oncology Letters 2019; doi: 10.3892/ol.2019.10701
|
| 24 |
Pamela Lu, Adam C. Fields, Jeffrey A. Meyerhardt, Jennifer S. Davids, Galyna Shabat, Ronald Bleday, Joel E. Goldberg, Garrett M. Nash, Nelya Melnitchouk. Systemic chemotherapy and survival in patients with metastatic low‐grade appendiceal mucinous adenocarcinoma. Journal of Surgical Oncology 2019; 120(3) doi: 10.1002/jso.25599
|
| 25 |
Paul H. McClelland, Stephanie N. Gregory, Shirley K. Nah, Jonathan M. Hernandez, Jeremy L. Davis, Andrew M. Blakely. Predicting Survival in Mucinous Adenocarcinoma of the Appendix: Demographics, Disease Presentation, and Treatment Methodology. Annals of Surgical Oncology 2024; 31(9) doi: 10.1245/s10434-024-15526-z
|
| 26 |
John Paul Shen, Abdelrahman M. Yousef, Fadl A. Zeineddine, Mohammad A. Zeineddine, Rebecca S. Tidwell, Karen A. Beaty, Lisa C. Scofield, Safia Rafeeq, Nicholas Hornstein, Elizabeth Lano, Cathy Eng, Aurelio Matamoros, Wai Chin Foo, Abhineet Uppal, Christopher Scally, Paul Mansfield, Melissa Taggart, Kanwal P. Raghav, Michael J. Overman, Keith Fournier. Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma. JAMA Network Open 2023; 6(6) doi: 10.1001/jamanetworkopen.2023.16161
|
| 27 |
Xiaoyun Gao, Hang Guan, Yiyao Li, Liduo Kou, Hua Tian, Junhui Jia, Wei Bai, Yu Bai, Yanhui Di, Ruiqing Ma, Xinhua Wang. The impact of anemia within 24 h after surgery on the prognosis of patients with pseudomyxoma peritonei. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1487823
|
| 28 |
Sarah E. Umetsu, Sanjay Kakar. Staging of appendiceal mucinous neoplasms: challenges and recent updates. Human Pathology 2023; 132 doi: 10.1016/j.humpath.2022.07.004
|
| 29 |
Celina S.-P. Ang, John Paul Shen, Camille J. Hardy-Abeloos, Justin K. Huang, Jeffrey S. Ross, Vincent A. Miller, Miriam T. Jacobs, Ingrid L. Chen, David Xu, Siraj M. Ali, Joel Baumgartner, Andrew Lowy, Paul Fanta, Trey Ideker, Sherri Z. Millis, Olivier Harismendy. Genomic Landscape of Appendiceal Neoplasms. JCO Precision Oncology 2018; (2) doi: 10.1200/PO.17.00302
|
| 30 |
Robert F. Bradley, Norman J. Carr. Pseudomyxoma Peritonei: Pathology, a Historical Overview, and Proposal for Unified Nomenclature and Updated Grading. AJSP: Reviews and Reports 2019; 24(3) doi: 10.1097/PCR.0000000000000305
|
| 31 |
Nuha Shaker, Jon Davison, Joshua Derby, Ibrahim Abukhiran, Akila Mansour, Matthew Holtzman, Haroon Choudry, Reetesh K. Pai. TP53 Alterations Are an Independent Adverse Prognostic Indicator in Pseudomyxoma Peritonei of Appendiceal Origin Following Cytoreductive Surgery and Intraperitoneal Chemotherapy. Applied Immunohistochemistry & Molecular Morphology 2025; 33(2) doi: 10.1097/PAI.0000000000001245
|
| 32 |
Abdelrahman Yousef, Mahmoud Yousef, Mohammad A. Zeineddine, Aditya More, Mohammad Fanaeian, Saikat Chowdhury, Mark Knafl, Paul Edelkamp, Ichiaki Ito, Yue Gu, Vinay Pattalachinti, Zahra Alavi Naini, Fadl A. Zeineddine, Jennifer Peterson, Kristin Alfaro, Wai Chin Foo, Jeff Jin, Neal Bhutiani, Victoria Higbie, Christopher P. Scally, Bryan Kee, Scott Kopetz, Drew Goldstein, Madeleine Strach, Andrew Williamson, Omer Aziz, Jorge Barriuso, Abhineet Uppal, Michael G. White, Beth Helmink, Keith F. Fournier, Kanwal P. Raghav, Melissa W. Taggart, Michael J. Overman, John Paul Shen. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma. JAMA Network Open 2024; 7(2) doi: 10.1001/jamanetworkopen.2024.0260
|